tbuckley/cabot-search huggingface dataset:
Development of Novel CD138 Antigen-Specific Peptide Capable of Eliciting Myeloma-Specific Cytotoxic T Lymphocytes Response.
Authors: Jooeun Bae, Jeff Martinson, Tai Yu-Tzu, Paola Neri, Pierfrancesco Tassone, Xianfeng Li, Rory Coffey, Zhinan Xia, Rao Prabhala, Kenneth Anderson, Nikhil Munshi
Journal: Blood (2005)
Real Life Analysis of the Rete Ematologica Lombarda on ELN Favorable Acute Myeloid Leukemia: The Molecular Remission Is a Necessary Goal for a Good Outcome in All Different Cytogenetic/Molecular Subgroups
Authors: Patrizia Zappasodi, Laura Marbello, Erika Borlenghi, Monica Fumagalli, Massimo Bernardi, Nicola Stefano Fracchiolla, Matteo Da Vià, Marianna Rossi, Emanuele Ravano, Elisa Cerqui, Virginia Valeria Ferretti, Mario Cazzola, Carlo Castagnola, Giuseppe Rossi
Journal: Blood (2015)
Platelet Adhesion Under Flow Condition in Patients with Essential Thrombocythemia (ET) and Polycythemia Vera (PV): Analysis According to the Mutational Status
Authors: Alfonso Vignoli, Serena Tessarolo, Marina Marchetti, Sara Gamba, Francesca Piras, Guido Finazzi, Paola van der Meijden, Frauke Swieringa, Hugo ten Cate, Johan Heemskerk, Alessandro Rambaldi, Anna Falanga
Journal: Blood (2015)
Association of Peripheral Regulatory T Cells with Achievement of Deep Molecular Response in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Treated with Dasatinib - the Final Results of D-First Study
Authors: Chikashi Yoshida, Noriyoshi Iriyama, Yuho Najima, Shin Fujisawa, Hisashi Wakita, Shigeru Chiba, Shinichiro Okamoto, Kimihiro Kawakami, Naoki Takezako, Takashi Kumagai, Kazuma Ohyashiki, Jun Taguchi, Shingo Yano, Tadahiko Igarashi, Yasuji Kouzai, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki, Koiti Inokuchi
Journal: Blood (2016)
High Cure Rates of the Short-Term GITIL Chemotherapy Programme for Adult Patients with Burkitt Lymphoma
Authors: Jacopo Mariotti, Anna Guidetti, Michele Magni, Paola Matteucci, Liliana Devizzi, Andrés J.M. Ferreri, Paolo Corradini, Anna Dodero, Amalia De Renzo, Alessandro Massimo Gianni, Massimo Di Nicola
Journal: Blood (2014)
Pevonedistat (MLN4924), an Investigational, First-in-Class NAE Inhibitor, in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML) Considered Unfit for Conventional Chemotherapy: Updated Results from the Phase 1 C15009 Trial
Authors: Ronan T Swords, Michael R Savona, Michael B Maris, Harry P Erba, Jesus G. Berdeja, James M. Foran, Zhaowei Hua, Hélène M Faessel, Ajeeta B Dash, Farhad Sedarati, Bruce J Dezube, Bruno C Medeiros
Journal: Blood (2014)
Integrated Analysis of High-Resolution Gene Expression and Copy Number Profiling Identified Biallelic Deletion of CDKN2A/2B Tumor Suppressor Locus As the Most Frequent and Unique Genomic Abnormality in Diffuse Large B-Cell Lymphoma (DLBCL) with Strong Prognostic Value in Both GCB and ABC Subtypes and Not Overcome by a Dose-Intensive Immunochemotherapy Regimen Plus Rituximab. Results of a Prospective GELA Clinical Trial Program
Authors: Fabrice Jardin, Sylvain Mareschal, Martin Figeac, Jean-Philippe Jais, Karen Leroy, Christiane Copie-Bergman, Gilles Andre Salles, Bertrand Coiffier, Richard Delarue, Frederic Peyrade, Andre Bosly, Nicolas Ketterer, Corinne Haioun, Herve Tilly, Thierry Jo Molina
Journal: Blood (2012)
Delayed Processing of Bone Marrow Samples Reveals a Prognostic Pattern of NME mRNA Expression in Cytogenetically Normal AML
Authors: Enrica Bach, Rainer Krahl, Sabine Tschiedel, Thoralf Lange, Frank Schüler, Haifa K. Al-Ali, Thomas Büchner, Gottfried Doelken, Dietger Niederwieser, Michael Cross
Journal: Blood (2011)
Collection of Hematopoietic Stem Cells After Previous Exposure to Ittrium-90 Ibritumumab Tiuxetan (Zevalin) Is Feasible and Does Not Impair Autologous Stem Cell Transplantation Outcome in Follicular Lymphoma.
Authors: Enrico Derenzini, Cinzia Pellegrini, Roberto Maglie, Vittorio Stefoni, Alessandro Broccoli, Letizia Gandolfi, Beatrice Casadei, Federica Quirini, Lisa Argnani, Stefano Fanti, Maria Rosa Motta, Michele Baccarani, Pier Luigi Zinzani
Journal: Blood (2012)
TARC before ASCT Is Highly Predictive of Outcome in Patients with Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL) after First-Line Therapy
Authors: Simonetta Viviani, Francesco Spina, Arabella Mazzocchi, Maria Galbiati, Flavio Crippa, Lucia Farina, Anna Guidetti, Massimo Di Nicola, Liliana Franca Devizzi, Paola Matteucci, Michele Magni, Anna Dodero, Alessandro M. Gianni, Paolo Corradini
Journal: Blood (2016)
The Predictive Factors of Favorable Prognosis after Allo-HSCT for Refractory Acute Leukemia
Authors: Kyoko Fuse, Takayuki Katagiri, Yasuhiko Shibasaki, Tomoyuki Tanaka, Miwako Narita, Hirohito Sone, Masayoshi Masuko, Tatsuo Furukawa, Naoko Sato, Toshio Yano, Takashi Kuroha, Shigeo Hashimoto, Takashi Ushiki
Journal: Blood (2016)
Q&amp;A: Mikala Egeblad on Tumor Microenvironment
Authors: Mikala Egeblad, Suzanne Rose
Journal: Cancer Discovery (2014)

Mikala Egeblad, PhD, who studies tumor microenvironment at New York's Cold Spring Harbor Laboratory, talks about how a tumor's microenvironment may affect therapeutic responses and disease metastasis, as well as future research directions in the field.
Low-Dose Dexamethasone Does Not Abrogate the Immunomodulatory Effects of Lenalidomide and Both Reactivate the Impaired Immune System of High-Risk Smoldering Multiple Myeloma Patients
Authors: Bruno Paiva, Maria-Victoria Mateos, Luis Ignacio Sánchez-Abarca, Maria Belen Vidriales, Lucia Lopez-Corral, Luis A Corchete, Miguel T Hernandez, Joan Bargay, Felipe De Arriba, Javier De La Rubia, Ana Isabel Teruel, Pilar Giraldo, Laura Rosiñol, Felipe Prosper, Albert Oriol, Jose Mariano Hernandez, Graça Esteves, Fernando Leal da Costa, Juan Jose Lahuerta, Joan Blade, Jose A. Perez-Simon, Jesus San Miguel
Journal: Blood (2015)
Analysis of the Impact of KIR B Haplotype Donors on Outcomes after Haploidentical (HI) and Matched Related (MR) Hematopoietic Stem Cell Transplantation (HSCT)
Authors: Praveen Ramakrishnan Geethakumari, Rasmi G Nair, Rachael Grosso, Neal Flomenberg, Dolores Grosso
Journal: Blood (2016)
The Multi-Kinase Inhibitor Sorafenib Blocks Migration, BCR Survival Signals, Protein Translation and Stroma-Mediated Bortezomib Resistance in Mantle Cell Lymphoma
Authors: Silvia Xargay-Torrent, Monica López-Guerra, Ifigènia Saborit-Villarroya, Laia Rosich, Alba Navarro, Neus Villamor, Marta Aymerich, Patricia Perez-Galan, Gael Roue, Elias Campo, Dolors Colomer
Journal: Blood (2012)
Differential Expression of SHP-1 Levels in Chronic Phase and Advanced Disease CML and in AML Patients
Authors: Jaspal S Kaeda, Christian Oberender, Daniel Neuman, Theo Kim, Ken I Mills, Anna Serra, Philipp Hemmati, Regina Schleede, Tim Overkamp, Frauke Ringel, Thomas Pretzsch, Seval Turkmen, Michaela Schwarz, Renate Arnold, Bernd Dörken, Philipp le Coutre
Journal: Blood (2012)
Early detection of pancreatic ductal adenocarcinoma by measuring the abnormal urinary fragmentation ratios of kininogen
Authors: Motoyasu Kan, Shuichi Mitsunaga, Izumi Ohno, Masafumi Ikeda, Hironobu Tsubouchi, Shigehisa Yanagi, Nobuhiro Matsumoto, Nobuaki Okumura, Toshifumi Takao, Masamitsu Nakazato
Journal: Annals of Oncology (2019)
Imaging Thromboembolism with 99mtc Labelled Chimeric Monoclonal Anti-Platelet Glycoprotein Iiia Antibody Fragment chSZ21F(ab)2: Evaluation In Beagle Canines
Authors: Shundong Ji, Wei Fang, Ningzheng Dong, Zuoxiang He, Changgeng Ruan
Journal: Blood (2010)
Immune Defects of B- and T-Cell Compartments in Natalizumab-Induced Progressive Multifocal Leukoencephalopathy,
Authors: Alessandra Sottini, Ruggero Capra, Cinzia Zanotti, Marco Chiarini, Federico Serana, Cinzia Lamorgese, Marina Motta, Doris Ricotta, Luigi Caimi, Luisa Imberti
Journal: Blood (2011)
An ER Assembly Line of AMPA-Receptors Controls Excitatory Neurotransmission and Its Plasticity
Authors: Jochen Schwenk, Sami Boudkkazi, Maciej K. Kocylowski, Aline Brechet, Gerd Zolles, Thorsten Bus, Kaue Costa, Astrid Kollewe, Johannes Jordan, Julia Bank, Wolfgang Bildl, Rolf Sprengel, Akos Kulik, Jochen Roeper, Uwe Schulte, Bernd Fakler
Journal: Neuron (2019)
Outcomes Following Salvage Autologous Stem Cell Transplant (ASCT2) Vs Low Dose Alkylating Consolidation Therapy Following Bortezomib-Containing Re-Induction for Relapsed Multiple Myeloma (MM) May be Dependent on Age and Symptomatic Status Initiation of Re-Induction: Results from the Myeloma X (Intensive) Trial
Authors: John Ashcroft, David A Cairns, Cathy Williams, A Hockaday, J. D. Cavenagh, John A Snowden, Christopher Parrish, Kwee L Yong, Jim Cavet, Hannah Hunter, Jennifer Bird, Guy Pratt, Sally Chown, Earnest Heartin, Sheila J.M. O'Connor, Julia Brown, Curly Morris, Gordon Cook
Journal: Blood (2015)
A Decade Follow-up of a Thalassemia Major (TM) Cohort Monitored by Cardiac Magnetic Resonance Imaging (CMR): Significant Reduction In Patients with Cardiac Iron and In Total Mortality
Authors: Alison S Thomas, Maciej Garbowski, Ai Leen Ang, Farrukh T Shah, J. Malcolm Walker, James C Moon, Dudley J Pennell, John B Porter
Journal: Blood (2010)
Treatment Patterns and Adherence Among Patients with Myelodysplastic Syndromes Receiving Deferasirox As Iron Chelation Therapy: A Real World Medicare Database Study
Authors: Alex Z Fu, Yanni Hao, Austin Coe, Ying Qiu, Zhiyi Li, Becky Hanna, Jackson Tang, Brian M. Elliott, Carole Paley
Journal: Blood (2016)
Unrelated-Donor PBSC Collection Facilitated by the NMPD, 1999–2005: Efficacy and Toxicities, Serious Unexpected Events, and Outcomes of Standard vs. Large Volume Collections.
Authors: Michael Pulsipher, S. Kurian, S. F. Leitman, P. Anderlini, M. Haagenson, B. Logan, M. M. Horowitz, D. L. Confer
Journal: Blood (2005)
Preliminary Phase 1 Results of the PD-1 Inhibitor ABBV-181 in Japanese vs Western Patients With Advanced Solid Tumors
Authors: Yasutoshi Kuboki, Shunsuke Kondo, Rasco Drew, Powderly John, Spira Alexander, J. luke Jason, Afar Daniel, Englert Stefan, Hideyuki Hashiba, Lambert Stacie, Parikh Apurvasena, Eisuke Shimizu, Vosganian Greg, Toshihiko Doi, Noboru Yamamoto
Journal: Annals of Oncology (2019)
PDGFRα and CD51 Mark Human Nestin+ Sphere-Forming Mesenchymal Stem Cells Capable of Robust Hematopoietic Stem Cell Expansion
Authors: Sandra Pinho, Julie Lacombe, Maher Hanoun, Ingmar Bruns, Yuya Kunisaki, Toshihide Mizoguchi, Paul S. Frenette
Journal: Blood (2012)
Next Generation Sequencing Identifies a Distinct Transcriptional Profile, Including Isoform Dysregulation That Segue with Genomic Alterations in Waldenstrom's Macoglobulinemia
Authors: Zachary Hunter, Lian Xu, Guang Yang, Nicholas Tsakmaklis, Xia Liu, Jie Chen, Robert R Manning, Jiaji Chen, Christopher J Patterson, Jorge J Castillo, Kenneth C Anderson, Nikhil C. Munshi, Steven P Treon
Journal: Blood (2015)
High WT1 Expression Has An Independent Positive Influence On CR Rate and EFS in Non M3 AML Patients Treated with Chemotherapy.
Authors: Nicoletta Colombo, Raffaella Grasso, Maurizio Miglino, Marino Clavio, Gianmatteo Pica, Germana Beltrami, Micaela Bergamaschi, Carlo Marani, Antonia Cagnetta, Anna Ghiso, Laura Mitscheunig, Ivana Pierri, Filippo Ballerini, Letizia Canepa, Sara Aquino, Enrico De Astis, Angelo Michele Carella, Marco Gobbi
Journal: Blood (2009)
Aldehyde Dehydrogenase-Positive Hematopoetic Progenitor Cells in Peripheral Blood and Progenitor Cell Apheresis Products: Characterization and Correlation with Kinetics of Engraftment.
Authors: Martin Hildebrandt, Markus Schuler, Kirstin Rautenberg, Christian Gerecke, Wolf-Dieter Ludwig
Journal: Blood (2005)
Risk Factors for Overall Survival in Patients with Acute Myeloid Leukemia (AML) with Normal Karyotype Undergoing Allogeneic Stem Cell Transplantation (allo-SCT) in First Complete Remission (CR1): A Report On 366 Patients From the Acute Leukemia Working Party of EBMT
Authors: Christoph Schmid, Myriam Labopin, Eric Deconinck, Michel Attal, Gérard Socié, Stephane Vigouroux, Liisa Volin, Norbert Ifrah, Alessandro Rambaldi, Jean-Francois Rossi, Didier Blaise, Jan Cornelissen, Per T. Ljungman, Mats L Brune, Pierre Bordigoni, Jean-Paul Vernant, Ibrahim Yakoub-Agha, Enrico Maria Pogliani, Mauricette Michallet, William Arcese, Emmanuelle Polge, Jordi Esteve, Mohamad Mohty
Journal: Blood (2012)
Expression of S100A8 in Leukemic Cells Predicts Poor Survival in De Novo AML Patients.
Authors: Pascal Mossuz, Emmanuelle Nicolas, Claire Ramus, Sylvie Berthier, Marie Arlotto, Christine Lefebvre, Françoise Morel, Jérome Garin, Norbert Ifrah, François Berger, Jean-Yves Cahn
Journal: Blood (2009)
The Prognostic Impact of KIT D816 Mutations in Core Binding Factor Acute Myeloid Leukemia
Authors: Shunsuke Yui, Saiko Kurosawa, Hiroki Yamaguchi, Heiwa Kanamori, Toshimitsu Ueki, Nobuhiko Uoshima, Ishikazu Mizuno, Katsuhiro Shono, Kensuke Usuki, Yasushi Okoshi, Yukinori Nakamura, Masamitsu Yanada, Junya Kanda, Kenji Tajika, Seiji Gomi, Keiko Fukunaga, Satoshi Wakita, Takeshi Ryotokuji, Takahiro Fukuda, Koiti Inokuchi
Journal: Blood (2016)
A Spin-Off in Non Valvular Atrial Fibrilation (NVAF) and Cancer : Doacs As a Safe and Effective Alternative to the Convencional Avks
Authors: Erik Johansson, Pável Olivera, Tania Canals, Francesc Bosch, Verónica Pons, Amparo Santamaría, Vicente Cortina
Journal: Blood (2016)
The Rheumatoid Arthritis Drug Auranofin Has Significant in Vitro Activity in MCL and DLCL and Is Synergistic with a Glutathione Depleting Agent
Authors: Jolanta Skalska, Michelle M. Kiebala, Shannon P. Hilchey, Yun Dai, Steven Grant, Paul S. Brookes, Derick R. Peterson, Sanjay B. Maggirwar, Steven H. Bernstein
Journal: Blood (2012)
Woman who had baby with Down’s syndrome after not being screened wins bid for compensation
Authors: Clare Dyer
Journal: BMJ (2019)

The mother of a 4 year old boy with Down’s syndrome has won a High Court battle for compensation from an NHS trust that failed in its duty to ensure that her wishes to undergo prenatal testing were properly carried out.1

Edyta Mordel, then aged 28, was pregnant for the first time and was booked for all usual first trimester scans at 12 weeks in July 2014. But the sonographer recorded, “Down’s testing refused,” and the combined ultrasound nuchal translucency test and blood testing were never carried out.

When she returned to see the community midwife at 16 weeks she was not offered the quadruple blood test for Down’s syndrome, which can …
STAT3 Deletion In Hematopoietic Tissue Causes Mitochondrial Dysfunction with Increased ROS Leading to LT-Repopulating Stem Cell Depletion, Erythroid Dysplasia, Peripheral Neutrophilia, and a Rapid Aging-Like Phenotype.
Authors: Charlie Mantel, Steve Messina-Graham, Akira Moh, Xin-Yuan Fu, Hal E. Broxmeyer
Journal: Blood (2010)
The Growth Factor Independence 1 variant form GFI136N Predisposes to Acute Myeloid Leukemia by Inducing Epigenetic Changes in Oncogenes Such As Hoxa9
Authors: Cyrus Khandanpour, Joseph Krongold, Judith Schütte, Frederique Bouwman, Lothar Vassen, Marie-Claude Gaudreau, Riyan Chen, Sara E. Meyer, H. Leighton Grimes, Bert A. Van der Reijden, Joop H. Jansen, Bob Lowenberg, Justine K Peeters, Patel Chandrashekhar, Ulrich Duehrsen, Berthold Goettgens, Tarik Moroy
Journal: Blood (2011)
Cytogenetic and Molecular Genetic Clonal Evolution in CLL Is Associated with an Unmutated IGHV Status and Frequently Leads to a Combination of Loss of 17p and TP53 mutation
Authors: Claudia Haferlach, Sabine Jeromin, Niroshan Nadarajah, Melanie Zenger, Wolfgang Kern, Torsten Haferlach
Journal: Blood (2016)
Improved Outcomes of Autologous (Auto) Hematopoeitic Stem Cell Transplantation (HSCT) for Intermediate and High Risk (I/HR) Aggressive (AG) Non Hodgkin Lymphoma (NHL) with IV vs PO Busulfan (Bu) in a Bu, Cyclophosphamide (Cy) and Etoposide (E) Preparative Regimen.
Authors: Charu Aggarwal, Sameer Gupta, Donna E. Salzman, Amy G. Dickey, William P. Vaughan
Journal: Blood (2004)
Evaluation of Quality of Biomarker Data Capture by Peripheral Sites in an International, Cooperative Study: Analysis of 104 Cases From the T-Cell Project.
Authors: Stefano A. Pileri, Monica Bellei, Julie M Vose, Joseph M. Connors, Francine M. Foss, Steven M. Horwitz, Silvia Montoto, Aaron Polliack, Pier Luigi Zinzani, Emanuele Zucca, Young-Hyeh Ko, Massimo Federico
Journal: Blood (2012)
Comparative Genomic Identification of Unique Signal Transduction Pathways and Targets In Pediatric Burkitt Lymphoma (PBL)
Authors: Nancy S Day, Janet Ayello, Ian Waxman, Carmella van de Ven, Megan S. Lim, Sherrie L. Perkins, Warren G. Sanger, Lauren Harrison, Stan Goldman, Mitchell S. Cairo
Journal: Blood (2010)
The Comparison of Hemostatic Effects of Recombinant Activated Factor VII (rFVIIa) in Thrombocytopenic Patients (pts) and Hemophilia Pts with Inhibitors
Authors: Gennadii M. Galstian, Irina V. Kolosova, Eduard Gemdzhian, Vladimir Yu. Zorenko, Tatyana A. Polyanskaya, Elena B. Orel, Valeri G. Savchenko
Journal: Blood (2015)
The Extent in Telomere Attrition and the Number of Affected Leukocyte Subsets Distinguishes Patients with Different Myeloproliferative Neoplasms (MPN).
Authors: Dirk de Beer, Elke Beutler, Adrian Emanuel Schmidt, Lucie Kopfstein, Elisabeth Oppliger Leibundgut, Gabriela M. Baerlocher
Journal: Blood (2009)
Ofatumumab, a Human Mab Targeting a Membrane-Proximal Small-Loop Epitope On CD20, Induces Potent NK Cell-Mediated ADCC.
Authors: Jenny L Craigen, Wendy J.M. Mackus, Patrick Engleberts, Sam R Miller, Sue Speller, Louise C Chamberlain, Bill G Davis, Simon M McHugh, Ed Bullmore, Charles J Cox, Sally Wetten, Gerrard Perdock, Joost M Bakker, Jan G. J. van de Winkel, Paul W. H. I. Parren
Journal: Blood (2009)
Myeloid-Derived Suppressor Cells in Patients with Hodgkin Lymphoma.
Authors: Nunziatina Parrinello, Piera La Cava, Daniele Tibullo, Cesarina Giallongo, Orazio Di Bartolo, Paolo Spina, Paolo Fiumara, Luciana Schinocca, Concetta Conticello, Annalisa Chiarenza, Giuseppe A Palumbo, Francesco Di Raimondo
Journal: Blood (2009)
A Phase I Study of Allogeneic Natural Killer Cell Therapy Generated from Cord Blood Hematopoietic Stem and Progenitor Cells in Elderly Acute Myeloid Leukemia Patients
Authors: Harry Dolstra, Mieke W.H. Roeven, Jan Spanholtz, Basav Hangalapura, Marleen Tordoir, Frans Maas, Marij Leenders, Fenna Bohme, Nina Kok, Carel Trilsbeek, Jos Paardekooper, Anniek B. Van der Waart, Peter Westerweel, Tjeerd J.F. Snijders, Gerard M.J. Bos, Jan J. Cornelissen, Hans Pruijt, Gerwin Huls, Aniek de Graaf, Bert A. van der Reijden, Nicole M.A. Blijlevens, Joop H. Jansen, Arnold van der Meer, Jeannette Cany, Frank Preijers, Nicolaas P.M. Schaap
Journal: Blood (2015)
Meta-analysis of laparoscopic groin hernia repair with or without mesh fixation
Authors: Mokhtar Eltair, Shahin Hajibandeh, Shahab Hajibandeh, Sankar Balakrishnan, Ahmad Alyamani, Daniel Radoi, Yan Li Goh, Mohamed Hanif, Yogesh Kumar, Dham Mobarak
Journal: International Journal of Surgery (2019)
Mechanisms in Leukemia-Associated Chromosomal Translocations: Novel, High-Throughput Sequencing Method to Detect Topoisomerase II (TOP2) Cleavage Complexes Genome-Wide with Exact Base Resolution,
Authors: Carolyn A. Felix, Marie L. Carillo, Karen A. Urtishak, Isabelle C. Dragomir, Michele E. Paessler, Andrew D. Bantly, Marybeth Helfrich, Li-San Wang, Brian D. Gregory
Journal: Blood (2011)
JAK2 (V617F) positively regulates PD-L1 mRNA expression via STAT3/5 activation in MNP (PV and ET) patients
Authors: Sameer Ahmad Guru, Mamta P. Alpana, Rashid Mir, Imtiyaz A. Najar, Mariyam Zuberi, Naresh Gupta, Pramod Lali, Alpana Saxena
Journal: Annals of Oncology (2019)
Update on the Phase I Study of the Cyclin Dependent Kinase Inhibitor Dinaciclib (SCH 727965) In Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL): Confirmation of Clinical Activity and Feasibility of Long-Term Administration
Authors: Joseph M. Flynn, Jeffrey A. Jones, Leslie Andritsos, Kristie A. Blum, Amy J. Johnson, Josh Hessler, Elizabeth Wiley, Jennifer Poon, Karen Small, Paul Statkevich, Michael R. Grever, Rajat Bannerji, John C. Byrd
Journal: Blood (2010)
Significant in-Vitro Activity of a Novel JAK2 Inhibitor in Multiple Myeloma Associated with Preferential Cytotoxicity for CD45+ Myeloma Cells.
Authors: Vijay Ramakrishnan, Jessica Haug, Teresa Kimlinger, Timothy Halling, Linda Wellik, Animesh D. Pardanani, Ayalew Tefferi, S. Vincent Rajkumar, Shaji Kumar
Journal: Blood (2009)
MEDI-551, a Humanized Monoclonal Anti-CD19, in Adults with Relapsed or Refractory Advanced B-Cell Malignancies: Results From a Phase 1/2 Study
Authors: Andres Forero, Mehdi Hamadani, Michelle A. Fanale, Celeste M. Bello, Thomas J Kipps, Fritz Offner, Gregor Verhoef, Massimo Federico, Stephanie A. Gregory, Anne Sonet, Sarit Assouline, Jaime Pérez de Oteyza, Jose Francisco Tomas, Antonio Cuneo, Weiya Zhang, Trishna Goswami, Ramy Ibrahim, Zhenling Yao, Ronald Herbst, Bruce D. Cheson
Journal: Blood (2012)
DNA Methylation Profiling of Pediatric AML Reveals That Hypomethylation of MN1 Is Characteristic of Inv(16) AML and a Driver of MN1 Overexpression
Authors: Nicole S.D. Larmonie, Marry M. van den Heuvel-Eibrink, Askar Obulkasim, Valerie de Haas, Dirk Reinhardt, Martin Zimmermann, Jan Trka, Andre Baruchel, Ronald W. Stam, Rob Pieters, Maarten W.J. Fornerod, C. Michel Zwaan
Journal: Blood (2014)
Safety and Clinical Efficacy of Rapidly-Generated Trivirus-Directed T Cells After Allogeneic Hematopoietic Stem Cell Transplant
Authors: Ulrike Gerdemann, Usha L Katari, Jacqueline Keirnan, John A. Craddock, Janet Salinas, Hao Liu, Caridad Martinez, Alana Kennedy-Nasser, Kathryn Leung, Stephen Gottschalk, Adrian P. Gee, Robert A. Krance, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop, Ann M. Leen
Journal: Blood (2012)
Fiber Scaffold Patterning for Mending Hearts: 3D Organization Bringing the Next Step
Authors: Marleen Kristen, Madison J. Ainsworth, Nino Chirico, Casper F. T. van der Ven, Pieter A. Doevendans, Joost P. G. Sluijter, Jos Malda, Alain van Mil, Miguel Castilho
Journal: Advanced Healthcare Materials (2019)

Heart failure (HF) is a leading cause of death worldwide. The most common conditions that lead to HF are coronary artery disease, myocardial infarction, valve disorders, high blood pressure, and cardiomyopathy. Due to the limited regenerative capacity of the heart, the only curative therapy currently available is heart transplantation. Therefore, there is a great need for the development of novel regenerative strategies to repair the injured myocardium, replace damaged valves, and treat occluded coronary arteries. Recent advances in manufacturing technologies have resulted in the precise fabrication of 3D fiber scaffolds with high architectural control that can support and guide new tissue growth, opening exciting new avenues for repair of the human heart. This review discusses the recent advancements in the novel research field of fiber patterning manufacturing technologies for cardiac tissue engineering (cTE) and to what extent these technologies could meet the requirements of the highly organized and structured cardiac tissues. Additionally, future directions of these novel fiber patterning technologies, designs, and applicability to advance cTE are presented.
Compassionate Use of Sorafenib in Relapsed and Refractory Flt3-ITD Positive Acute Myeloid Leukemia.
Authors: Stephan Metzelder, Sebastian Scholl, Kröger Matthias, Andreas Reiter, Ralf G. Meyer, Thomas Heinicke, Aristoteles Giagounidis, Brugger Wolfgang, Mathias Vöhringer, Michael Stadler, Beate Schultheis, Lothar Müller, Mathias Hänel, Andreas Hochhaus, Erich Enghofer, Andreas Neubauer, Andreas Burchert
Journal: Blood (2009)
Targeting Phosphotyrosine-315 In RAD51 Recombinase to Prevent BCR-ABL1 - Mediated Unfaithful Homeologous Recombination Repair.
Authors: Artur Slupianek, Yashodhara Dasgupta, Shu-yue Ren, Kimberly Cramer, Tomasz Skorski
Journal: Blood (2010)
Activity of Lenalidomide in a Phase II Single Institution Study in Non-Del(5q) Transfusion Dependent, Patients with Low and Intermediate-1 Risklower-Risk, Non-Del(5q) Myelodysplastic Syndromes (MDS))): Results From a Single-Institution Phase II Study
Authors: Azra Raza, John Falkenstern, Fiona Yeh, Ginevra Castagna, Antonietta De Los Reyes, Naomi Galili
Journal: Blood (2012)